Monday, November 13, 2006
Large BPO pharma contract in TCS pocket
Tata Consultancy Services (TCS), India major software giant has bagged a large pharma BPO contract from Eli Lilly for providing drug development services, including clinical trial, data management, statistical analysis and medical writing. Although not disclosed by the company, the multi-year contract is estimated to be around $30-35 million.
Subscribe to:
Post Comments (Atom)
1 comment:
Eli Lilly litigation.
My issue is Zyprexa which is only FDA approved for schizophrenia (.5-1% of pop) and some bipolar (2% pop) and then an even smaller percentage of theses two groups.
So how does Zyprexa get to be the 7th largest drug sale in the world?
Eli Lilly is in deep trouble for using their drug reps to 'encourage' doctors to write zyprexa for non-FDA approved 'off label' uses.
The drug causes increased diabetes risk,and medicare picks up all the expensive fallout.There are now 7 states (and counting) going after Lilly for fraud and restitution.
--
Daniel Haszard
Post a Comment